Contract facts
FederalNo full NAICS 621999 intel page yet. Browse NAICS intelligence
DRUG AND ALCOHOL LABORATORY TESTING SERVICES is a federal award for Ibc Acq Svcs Directorate (00004) held by Quest Diagnostics Clinical Laboratories, Inc. Estimated value $561K ($455K obligated). Current period of performance ends Mar 31, 2026. Place of performance: SECAUCUS NJ. Related solicitation 140D0423D0020.
DRUG AND ALCOHOL LABORATORY TESTING SERVICES
Recompete timing
PublicCurrent PoP ended Mar 31, 2026 (143 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordQuest Diagnostics Clinical Laboratories, Inc — $1.1M obligated across 40 awards (firm-wide, all agencies) · lead buyer Department of the Interior (DOI).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 140D0425F0292?
140D0425F0292 (DRUG and alcohol laboratory testing services) is a Ibc Acq Svcs Directorate (00004) award with a potential value of $561K, currently held by Quest Diagnostics Clinical Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 140D04-25-F-0292?
140D04-25-F-0292 is the dashed form of PIID 140D0425F0292 (DRUG and alcohol laboratory testing services), held by Quest Diagnostics Clinical Laboratories, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 140D0425F0292?
Ibc Acq Svcs Directorate (00004) awarded 140D0425F0292 to Quest Diagnostics Clinical Laboratories, Inc (potential $561K).
Who is the incumbent on 140D0425F0292?
Quest Diagnostics Clinical Laboratories, Inc is the incumbent with $1.1M across 40 related awards in SCOUT’s public footprint. The current period of performance ends Mar 31, 2026.
When does Quest Diagnostics Clinical Laboratories, Inc’s 140D0425F0292 come up for recompete?
SCOUT tracks a period-of-performance end of Mar 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.